Gainers
- Qualigen Therapeutics QLGN shares moved upwards by 42.5% to $0.25 during Thursday's regular session. The company's market cap stands at $1.5 million. The company's, Q1 earnings came out 2 days ago.
- Sharps Technology STSS stock rose 33.56% to $0.31. The market value of their outstanding shares is at $6.1 million.
- Autonomix Medical AMIX shares increased by 21.43% to $0.78. The market value of their outstanding shares is at $14.6 million.
- Akso Health Group AHG stock rose 11.68% to $1.29. The company's market cap stands at $189.2 million.
- Conduit Pharmaceuticals CDT stock rose 10.74% to $0.71. The company's market cap stands at $52.3 million.
- FibroGen FGEN shares rose 10.54% to $0.76. The market value of their outstanding shares is at $75.9 million.
Losers
- Reshape Lifesciences RSLS stock declined by 7.0% to $0.21 during Thursday's regular session. The company's market cap stands at $4.9 million.
- CNS Pharma CNSP stock declined by 6.17% to $1.37. The company's market cap stands at $1.1 million.
- Tenon Medical TNON shares decreased by 5.78% to $0.72. The market value of their outstanding shares is at $2.7 million.
- Ainos AIMD stock fell 5.33% to $0.89. The market value of their outstanding shares is at $5.7 million.
- Tenax Therapeutics TENX shares fell 5.2% to $3.02. The company's market cap stands at $5.9 million.
- CareMax CMAX stock decreased by 5.11% to $2.23. The market value of their outstanding shares is at $8.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
AIMDAinos Inc
$0.47721.53%
AMIXAutonomix Medical Inc
$3.46-1.14%
CDTConduit Pharmaceuticals Inc
$0.05724.95%
CNSPCNS Pharmaceuticals Inc
$0.1070-1.83%
FGENFibroGen Inc
$0.51006.25%
QLGNQualigen Therapeutics Inc
$3.90-3.47%
RSLSReshape Lifesciences Inc
$4.628.45%
STSSSharps Technology Inc
$1.955.41%
TENXTenax Therapeutics Inc
$5.31-3.28%
TNONTenon Medical Inc
$1.782.30%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in